Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
· ·
$10.03
▲ $0.01 (+0.1%)
Market data updated: 09/19 05:24 PM
News analyzed: 09/19/2026
Market Cap
Not available
Day Range
$10.03 - $10.03
52-Week Range
$9.85 - $10.05
Beta
—
Next Earnings
—
Support
$9.93
Resistance
$10.05
+1.6% (1Y)
🟡 Moderate
Strengths: 5/11 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟡 Mixed
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Daily volatility (ATR)
ATR: 0.1% of price
Risk
Biggest negative driver
MACD
MACD histogram is negative — falling momentum
Technical
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 0 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 0
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
48
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
No data available
Quality
No data available
Value
No data available
Momentum
45
Risk
58
Sentiment
50
Fundamental
No data available
Institutional
100
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
🌡️ Emotional Temperature
2
🎯 Conviction (vs. Emotion)
50
Psychology
94
Fundamentals
—
Technical
45
Valuation
—
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price (3M)
+1%
Market Narrative
44
Fundamental Reality
50
Narrative Gap
-6
🧠 StockIQ Psychologist
The market’s extreme anchoring (96) suggests traders are fixated on the 0.2% resistance gap, ignoring other signals. FOMO is muted by modest momentum and volume, while euphoria remains dormant. The narrow narrative gap (-5) hints at a disconnect between sentiment and technicals, but the dominant bias is likely a reluctance to challenge the resistance anchor. The key question: *Will traders break the anchor, or will the stock test support instead?*
Updated: 09/07/2026, 04:53 PM
What could change this?
📈 7D Investor Psychology
Signal classification confidence: Medium (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Morgan Housel — 100/100
🔴 Weakest match
Jack Schwager — 37/100
🗣️ Why do they disagree?
The stark divide in verdicts for BHAV reflects a clash between methodologies that prioritize patient, qualitative growth and those that demand clear quantitative signals or market efficiency. Morgan Housel’s near-perfect score highlights his focus on long-term, value-creating compounders—here, the stock aligns with his principles of quiet, enduring growth. Meanwhile, Veblen and Mackay’s high scores suggest a consensus that the stock’s trajectory reflects real economic substance rather than speculative hype, though their thresholds are slightly lower than Housel’s. In contrast, Graham, Fisher, and Lynch’s middling scores stem from a lack of definitive fundamentals or valuation data, leaving their models unable to form a concrete opinion. At the opposite end, Nelson and Schwager’s low scores stem from technical or cyclical concerns—Nelson flags overbought conditions, while Schwager’s wizards would dismiss it for lacking a disciplined trading setup. The efficient-market camp’s skepticism further underscores the stock’s ambiguity, questioning whether its idiosyncrasies justify active selection over passive indexing.
Morgan Housel
The Psychology of Money (2020)
🟢 100
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 91
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 80
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 78
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 74
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 72
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 54
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 51
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 50
Not enough balance-sheet/valuation data for a real Graham read
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 50
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Peter Lynch
One Up on Wall Street (1989)
🟡 50
Not enough growth data for a real Lynch read
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Walter Bagehot
Lombard Street (1873)
🟡 50
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 50
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 37
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 37
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🔴 15
Not enough dividend/growth data for a real Smith read
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Based on the last 108 trading days, calculated from real price data. Click an indicator for details and a chart.
🟡 Indicators are mixed — no clear bias (4 bullish · 6 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a trading range, but the picture isn't yet clear enough on the likely direction.
Low confidence
$9.93
Range Bottom
$10.05
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Sentiment based on basic keywords (not AI) — 0 positive, 0 neutral, 0 negative out of the last 0 articles.
No recent articles found for this stock.
StockIQ doesn't currently have enough real data to compute a reliable score for BHAV Acquisition Corp (BHAV) — only 3 of 7 categories are available right now. Rather than show a misleading number, this page shows which data is missing instead.
StockIQ doesn't give buy/sell recommendations — and for BHAV specifically, there currently isn't enough real data (only 3 of 7 categories available) to state even a factual score reliably. Check back once more data is available.
BHAV's technical score is 45/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: ATR: 0.1% of price; Price is above the 50-day average; RSI 53.5 — healthy positive momentum.
Based on the real signals StockIQ computed: MACD histogram is negative — falling momentum; -1.2% over the last 3 months relative to the index; Price is below the SAR point — downtrend.
StockIQ has no recorded dividend payment history for BHAV.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 3 purchases and 0 sales out of the last 5 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| BHAV Partners LLC | Other Transaction | 3.5.2026 | 500,000 | -500,000 | — |
| Devanur Giri | Other Transaction | 3.5.2026 | 2,683,333 | -500,000 | — |
| BHAV Partners LLC | Open Market Purchase | 20.3.2026 | 135,000 | +135,000 | — |
| BHAV Partners LLC | Open Market Purchase | 20.3.2026 | 135,000 | +135,000 | — |
| Devanur Giri | Open Market Purchase | 20.3.2026 | 135,000 | +135,000 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
13,300 shares short as of 2026-08-31 · vs. 15,830 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
75.0% of trading volume this week was short selling, vs. 82.5% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology